USPTO To Reissue Seasonale Patent

Law360, New York (April 9, 2007, 12:00 AM EDT) -- The U.S. Patent and Trademark Office will reissue a patent related to Barr Pharmaceuticals Inc.’s oral contraceptive drug Seasonale, according to Barr, marking the latest development in the battle for the multimillion-dollar market for the drug.

Barr announced Monday that the PTO issued a Notice of Allowance for the reissuance of U.S. Patent Number 5,895,032, which relates to Seasonale. The PTO’s decision to hand down the Notice of Allowance means that Barr’s reissue patent application meets the requirements for patentability and that the PTO will reissue...
To view the full article, register now.